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ABSTRACT
Strategies to regulate gene function frequently use
small interfering RNAs (siRNAs) that can be made
from their shRNA precursors via Dicer. However,
when the duplex components of these siRNA effect-
ors are expressed from their respective coding
genes, the RNA interference (RNAi) activity is
much reduced. Here, we explored the mechanisms
of action of shRNA and siRNA and found the ex-
pressed siRNA, in contrast to short hairpin RNA
(shRNA), exhibits strong strand antagonism, with
the sense RNA negatively and unexpectedly regulat-
ing RNAi. Therefore, we altered the relative levels of
strands of siRNA duplexes during their expression,
increasing the level of the antisense component,
reducing the level of the sense component, or both
and, in this way we were able to enhance the
potency of the siRNA. Such vector-delivered siRNA
attacked its target effectively. These findings pro-
vide new insight into RNAi and, in particular, they
demonstrate that strand antagonism is responsible
for making siRNA far less potent than shRNA.
INTRODUCTION
RNA interference (RNAi) is an RNA-dependent gene-
silencing phenomenon and is initiated by  20-bp
double-stranded RNA in the cytoplasm (1–3). The
trigger for RNAi can be exogenous, for example, a syn-
thetic small interfering RNA (siRNA), or endogenous, for
example, a pre-micro RNA (miRNA)-like shRNA or
siRNA that is expressed from its respective gene within
the cell (4–9). Endogenous short hairpin RNA (shRNA)
and siRNA are transcribed in the nucleus and must be
exported to the cytoplasm, where the characteristic
stem–loop of shRNA is cleaved by Dicer (10,11). The
pathways involving siRNA and its shRNA precursor con-
verge at RNA-induced silencing complex (RISC), with
subsequent removal of the sense strand from the siRNA
duplex, presumably cleaved ﬁrst and then degraded, so
that the antisense strand within RISC can recognize
sequence-homologous RNAs and mediate target speciﬁ-
city (Figure 1). The recruited RNA is cleaved and degraded
without any effect on the antisense strand, such that the
antisense-programmed RISC is able to identify and
degrade multiple copies of the target RNA (1,12).
The selective and robust effect of RNAi on gene expres-
sion both in cell culture and in living organisms makes it a
valuable research tool (10). Compared to exogenous
siRNA, endogenous shRNA or siRNA, expressed via a
plasmid or a viral vector, has enormous advantages in
terms both of costless regeneration and long-term gene
silencing (4–7,13–15). siRNA is generated via concomitant
transcription of the integral sense and antisense strand
from the respective coding sequences, which can be
either a tandem or a convergent cassette (Figure 1); the
latter system holds further promise for the construction of
siRNA libraries for reasons both of convenience and of
template stability (6–8). shRNA is transcribed from its
unique template (16–19), a long and inverted-repeat
DNA sequence (palindrome), and then it is translocated
to the cytoplasm, where the hairpin loop is deleted to
generate siRNA.
The broad applicability of shRNA renders it very at-
tractive as a strong and versatile silencer of various genes
both via transient transfection and via stable transduction
(4,5,13–15). By contrast, expressed siRNA, even though it
is the actual trigger and, theoretically, should be more ef-
ﬁcient, is far less potent than its shRNA precursor (6–9).
To date and to our knowledge, expressed siRNA delivered
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gene with useful efﬁciency. This problem remains a chal-
lenge to those researchers in the RNAi ﬁeld and, especially
to those who are using lentiviral siRNA and correspond-
ing libraries for as potential biological and therapeutic
tools (8).
The sequences of expressed siRNA and its shRNA pre-
cursor in this study are identical except a loop that
links the sense and antisense duplexes in the latter case
(Figure 1). Many potential factors, either related or unre-
lated to this loop, might reduce the potency of siRNA,
such as poor transcription, due to potential interference
between opposing promoters; poor nucleo-cytoplamic
translocation; and/or poor incorporation into RISC due
to the absence of the loop. All these possibilities remain to
be explored. Recently, Berkhout group has tested the im-
pact of different hairpin loop sequences, varying in size
and structure, and found that the nature of a shRNA has
a rather major impact on the shRNA activity (20). In this
report, we provide evidence to suggest yet another possi-
bility, namely, that sense strand-mediated strand antag-
onism attenuates the potency of expressed siRNA.
Moreover, we show that reduction of this negative effect
via alterations in the relative levels of strands of siRNA
duplexes during their generation signiﬁcantly enhances the
potency of siRNA, in particular, in cases of stable trans-
duction. Our ﬁndings provide new insight into the
pathway of RNAi and should help us to develop strategies
for exploiting expressed siRNA as a more efﬁcient tool in
the future.
MATERIALS AND METHODS
Construction of various shRNA- and siRNA-expression
cassettes
We constructed shRNA and siRNA, two p53-targeting
siRNA-expression cassettes, by PCR ligation as described
previously (21,22). We also constructed shRNA(O),
siRNA(O), siRNA(O0) and siRNA(O2), four shRNA-
or siRNA-expression cassettes with one or two inducible
U6 promoters (Figure 2a), by the same method.
Additional four inducible siRNA expression cassettes tar-
geting ﬁreﬂy luciferase were also constructed with the
siRNA sequence as gtgcgctgctggtgccaaccc. We utilized a
similar approach for construction of siRNA-antisense,
siRNA-sense, shRNA-sense and shRNA-antisense, four
siRNA- or shRNA-expression cassettes that allowed an
additional antisense or sense strand to be generated, and
hU6/U6-siRNA-mU6/U6, hU6/U6/O-siRNA-mU6/U6,
hU6-siRNA-mU6/U6, hU6/O-siRNA-mU6/U6 and hU6-
siRNA-O/mU6/U6, ﬁve siRNA-expression cassettes with
one or two chimeric promoters. pSD31 was a lentivector
Figure 1. Schematic representation of RNAi and of the parameters that inﬂuence the difference between the potencies of siRNA and shRNA
generated within cells. The ability of the integral sense RNA to the active RISC (dotted line) in the presence of the true RNA target renders siRNA
far less potent than shRNA.
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transduction of siRNA, as reported previously (22).
Cell culture, transient transfection, stable transduction and
packaging and titration of the lentivector
The mammalian cells used for most of this study were
293FT cells, cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% fetal calf serum. The ex-
perimental protocols for expression of siRNA via transi-
ent transfection and stable transduction have been
described previously (8,22). Experiments involving
lentiviral packaging were performed by standard proto-
cols (Invitrogen, San Diego, CA, USA). In brief,
sub-conﬂuent 293FT packaging cells were co-transfected
with 20mg of a recombinant lenti-plasmid, 15mgo f
pCMV-DR8.91 and 5mg of pMD2G-VSVG by calcium
phosphate precipitation. Viral vectors were harvested
3 days after transfection. After ﬁltration, the titer of the
suspension of vector was determined as described by
‘Invitrogen’s’ protocol.
Western blotting analysis
Cells were washed with phosphate-buffered saline (PBS)
buffer, lysed in lysis buffer for 5min and passed through a
27-gauge needle. Lysates were cleared by centrifugation at
12000g for 1min, and the concentration of protein was
determined with a protein assay kit from Bio-Rad with
bovine serum albumin (BSA) as standard. Equal
amounts of protein were fractionated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE;
4–20% polyacrylamide) before transfer to nitrocellulose
membranes. Membranes were blocked with 3% BSA in
TBST (10mM Tris–HCl, pH 7.5, 150mM NaCl, 0.1%
Tween 20) for 1h at room temperature. Primary and sec-
ondary antibodies were used according to the manufac-
turer’s instructions, with detection with an enhanced
chemiluminescence kit (Amersham Biosciences,
Piscataway, NJ, USA).
Quantitation of mRNA, expressed siRNA duplexes and
shRNA by real-time reverse transcriptase-polymerase
chain reaction (RT-PCR)
Total RNA was prepared from 293FT cells in TRIzol
reagents (Invitrogen, San Diego, CA, USA). Nuclear
and cytoplasmic RNA were isolated as described previ-
ously (23). Standard quantitative real-time reverse
transcriptase-polymerase chain reaction (RT-PCR) was
performed to determine levels of expression of p53
mRNA, as described previously (22,24). Quantitative
analysis of expressed siRNA duplexes and shRNA in
transfected or transduced cells by real-time RT-PCR was
based on methods developed by others groups (25–27). In
brief, 1mg of total RNA was polyadenylated by poly(A)
polymerase plus adenosine triphosphate (ATP) at 37 C
for 1h in a 20-ml reaction mixture. After phenol–chloro-
form extraction and ethanol precipitation, the RNA was
dissolved in diethylpyrocarbonate (DEPC)-treated water
and reverse-transcribed with 200U of SuperScript
TM II
reverse transcriptase (Invitrogen, San Diego, CA, USA)
and 0.5mg of poly(T) adapter according to the protocol
from Invitrogen. For each real-time PCR, 1ml of template
cDNA, equivalent to  100pg of total RNA, was mixed
with 12.5mlo f2  SYBR Green PCR master mix and
Figure 2. (a) Schematic representation of shRNA-and siRNA-expression cassettes with the U6 or an inducible U6 promoter. pSD31 is a DNA
vector derived from pHIV-7 and pDual-Luci is a dual luciferase reporter system for simultaneous expression of ﬁreﬂy and renilla luciferase.
(b) Western blotting analysis of p53 knockdown in 293FT cells transfected with pSD31-shRNA and pSD31-siRNA.( c) Western blotting analysis
of p53 knockdown in 293FT cells transduced with pSD31-shRNA and pSD31-siRNA.
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volume of 25ml. Programs for ampliﬁcation by PCR were
the same as those described elsewhere (25–27) and all re-
actions were run in triplicate. The variation among tripli-
cate results did not exceed 15%.
Mapping of expressed siRNA and shRNA generated from
various expression cassettes
In order to verify siRNA effectors generated from various
expression cassettes were identical, the RNA transcripts
were captured by reverse transcription and ampliﬁed by
PCR. In brief, 1ml of cDNA template from the reverse
transcription of the total RNA, 47ml of PCR SuperMix
(Invitrogen, San Diego, CA, USA) and 1ml of each
forward and reverse primer with 200nM as ﬁnal concen-
tration were mixed and then carried out PCR according to
the manufacturer’s instructions. The PCR products were
puriﬁed by 2% agarose gel, cloned into TA vector and
then harvested from TOP10 cells for sequencing.
Testing the quality of the nuclear-cytosol fractionation
The nuclear-cytosol RNA fractionation was carried out
using Norgen’s Cytoplasmic & Nuclear RNA
Puriﬁcation Kit (Norgen, Ontario, Canada), which has
been proved as a rapid and efﬁcient method for the isola-
tion of cytoplasmic and nuclear RNA from cultured
animal cells and small tissue samples. According to the
manufacturer’s instructions, a small nuclear RNA, U2
snRNA, and a house-keeping transcript in the cytoplasm,
s14 RNA, were utilized as indicators via RT-PCR to dem-
onstrate the quality of nuclear-cytosol fractionation. The
speciﬁc primers for U2 snRNA were 50-CATCGCTTCTC
GGCCTTTTG-30 (forward) and 50-TGGAGGTACT GC
AATACCAGG-30 (reverse). The primers for ampliﬁcation
of S14 were 50-GGCA GACCGAGATGAATCCTC-30
(forward) and 50-CAGGTCCAGGGGTCTTGGTCC-30
(reverse). In addition, ribosomal RNA 28S and 18S were
also utilized as indicators to test the integrity and quality
of the isolated RNA.
RESULTS AND DISCUSSION
Expressed siRNA was far less potent than the
corresponding precursor shRNA
Unlike shRNA, siRNA expressed intracellularly has not
been extensively exploited for inactivation of gene expres-
sion by either transient transfection or stable transduction.
We chose the well-characterized p53 siRNA for our
analysis (4,22) and cloned two forms of its DNA coding
sequence (shRNA versus siRNA) into the vector pSD31
(Figure 2a). Then we compared their potency in the in-
activation of the expression of the p53 gene. Transient
transfection with pSD31-shRNA and pSD31-siRNA,i n
parallel, of 293FT cells indicated that expressed siRNA
was far less potent than shRNA, when analyzed by
western blotting: almost all expression of p53 was pre-
vented by the shRNA, while the expressed siRNA was
only moderately effective (Figure 2b). In stable transduc-
tion experiments with the lentiviral vector pSD31, siRNA
was inactive, while shRNA was a strong silencer of its
target gene (Figure 2c). The lower potency of expressed
siRNA as compared to shRNA has been reported simi-
larly by other groups who studied a variety of genes (6–8).
To date siRNA delivered via a viral vector has not been
shown to substantially disrupt the expression of any target
gene. However, we do not know why expressed siRNA,
the actual trigger of RNAi, is so much less effective than
its shRNA precursor.
Comparisons of intracellular expression of siRNA versus
shRNA
Many factors might be expected to affect the potency of
siRNA. Transcription might be impaired as a consequence
of opposing promoters, which might act in conﬂict with
one another during convergent expression of the sense and
antisense strands, with generation of fewer transcripts. In
order to examine this possibility, we quantiﬁed the levels
of siRNA and shRNA transcripts in transfected cells.
Northern blotting analysis indicated that DIG-labeled
probes were not sensitive enough to detect short RNA
(Supplementary Figure 1). Moreover, even when detection
was possible, quantitation of the tiny amounts of RNA
and the variations in levels was very difﬁcult, and the data
were often unreproducible (Supplementary Figure 1).
To overcome this problem, we used a previously re-
ported real-time RT-PCR technique (25–27) to quantify
expressed siRNA and shRNA (Supplementary Figure 2).
The empty vector pSD31 was used as a negative control
for comparisons of the relative levels of siRNA duplexes
and shRNA generated in transfected and transduced cells.
As shown in Figure 3a, we found that the sense and anti-
sense strands of siRNA gave almost the same cycle thresh-
old (Ct) values, namely 19.5 versus 19.4, indicating that
the strands were generated with equal efﬁciency. After
normalization (Supplementary Figure 2), the copy num-
bers of the sense and antisense strands of siRNA in each
well of a 6-well plate ( 0.25 10
6 cells transfected with
2mg of DNA with an efﬁciency of  90%, as determined
from a control with the gene for green ﬂuorescent protein)
were 7.1 10
7 and 7.3 10
7, respectively. In addition,
shRNA generated in a parallel experiment had a Ct
value of 19.2, which was very similar to that of siRNA
(Figure 3a), indicating that the number of copies of
shRNA in transfected cells was the same as that of
siRNA (Figure 3a). On the basis of these results, we
were able to predict that each transfected cell contained
an average of  300 copies of siRNA or shRNA tran-
scripts. These results excluded the possibility of poor gen-
eration of siRNA, at least the concentration of siRNA
detected, which is the sum of synthesis and degradation,
was almost similar as that of shRNA. Those data also
suggest that the opposing promoters within the siRNA
cassette did not interfere with one another and transcrip-
tion was efﬁcient as from a single promoter.
siRNA transcripts were able to export from the nucleus
into the cytoplasm
Export from the nucleus might also affect the potency of
expressed siRNA. Both expressed siRNA and shRNA are
1800 Nucleic Acids Research, 2012,Vol.40, No. 4generated in the nucleus but function in the cytoplasm
and, thus, must be exported across the nuclear envelope
(1,3,11). It has been demonstrated that shRNA, a struc-
tural homolog of pre-miRNA, exploits essentially the
same nucleocytoplasmic shuttle protein, Exportin-5, as
pre-miRNA. Exportin-5 recognizes the 30 two-nucleotide
overhang of the pre-miRNA hairpin for transportation of
this RNA into the cytoplasm (28–31). The absence of a
hairpin loop might impair the translocation of expressed
siRNA, causing lower levels of siRNA in the cytoplasm,
which is where RNAi is triggered.
To examine this possibility, we isolated nuclear and
cytoplasm RNAs from transfected cells and quantiﬁed
the respective levels of expressed siRNA and shRNA.
We ﬁrst tested the integrity and quality of the isolated
RNA. Analysis of U2 snRNA by RT-PCR indicated
that an intense product was observed when the nuclear
fraction rather than the cytoplasmic fraction was used as
the template (Supplementary Figure 3a). In contrast, the
majority of the PCR product for S14 was from the cyto-
plasmic fraction rather than the nuclear as the template
(Supplementary Figure 3b). In addition, the majority of
ribosomal RNA (28S and 18S) was in cytoplasm rather
than in nuclear as shown in Figure 3c, also indicating ef-
fective separation of cytoplasmic and nuclear RNA.
Combination of these data indicated that the cytoplasmic
and nuclear RNA were effectively separated.
As shown in Figure 3b, siRNA duplexes were detected
in the cytoplasm and nucleus with Ct values of 21.4 versus
25.5 for the sense strand and 21.5 and 25.2 for the anti-
sense strand, respectively. We also detected shRNA in
both the cytoplasm and nucleus with Ct values of 21.4
and 24.4, respectively. These data indicate that the
siRNA duplex, despite the absence of the hairpin loop,
was able to transport into the cytoplasm just like
shRNA. It remains unclear how siRNA, either as separate
individual strands or as paired strands, is exported, but it
was clearly not a difference in translocation that caused
the difference in potency between siRNA and shRNA.
Expressed siRNA exhibited strand antagonism in
triggering RNAi
In a previous study, we found that the lentiviral packaging
system was an ideal model for elucidating the roles of in-
dividual strands of siRNA in triggering RNAi since the
siRNA-delivering viral vector itself is an inherent target
(8). We found, previously, that blocking transcription of
the antisense strand inactivated RNAi completely. By
contrast, blocking transcription of the sense strand had
almost no effect on the potency of expressed siRNA (8).
These observations let us to ask a fundamental question: is
the sense strand really necessary for RNAi? In addition,
we wondered whether ‘extra’ integral sense or antisense
RNA might enhance the potency of siRNA. To answer
these questions, we designed a series of experiments to
detect the effects of changes in relative levels of the
strands of siRNA duplexes on RNAi.
As reported previously (8,21,22), an inducible U6
promoter with a tetracycline operator (TetO or O)
reduced transcription of shRNA by  20%. Therefore,
we replaced one of the two U6 promoters within the
siRNA-expression cassette with the inducible promoter
(Figure 2a), which reduced the expression of the anti-
sense or sense RNA to the same extent (20%) as
reported previously (8,22). Map mapping data indicated
that the sequences of siRNA duplexes generated from
various siRNA-expression cassettes were identical
(Supplementary Figure 4). Such a reduction in the level
of the antisense RNA [pSD31-siRNA(O)] increased the
titer of lentivector almost 2-fold (Figure 4a and b), sug-
gesting the potency of RNAi decreased slightly since the
siRNA-carrying viral RNA itself is an inevitable target of
RNAi (8,22). This result was consistent with the hypoth-
esis that the antisense RNA is the predominant effective
inducer of RNAi (32–35). By contrast, reduction in the
level of the sense RNA [pSD31-siRNA(O’)] tended to
increase RNAi with a lower titer of the lentivector being
produced (Figure 4a and b), hinting that the sense com-
ponent might act as an inhibitory factor. Consistently, the
increase in potency caused by reduction in the level of the
sense component vanished with a similar simultaneous re-
duction in the level of the antisense component [pSD31-
siRNA(O2)]. Together, these observations suggested that
equivalent levels of the sense and antisense components
rendered the siRNA less potent.
Conﬁrmation of strand antagonism in RNAi
To conﬁrm that the sense strand really reduced the potency
of the siRNA, we expressed ‘extra’ sense RNA by ligating
Figure 3. (a) Levels of the expression of siRNA duplexes and shRNA
in transfected and transduced 293FT cells, as determined by real-time
RT–PCR. (b) The distribution of siRNA duplexes and shRNA in the
cytoplasm and the nucleus. All data shown reﬂect results from experi-
ments conducted in triplicate for each sample.
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(Figure 5a). As expected, this cassette engineering
(siRNA-sense) eliminated the equivalence of the sense ver-
sus the antisense component, with the level of the former
being close to twice that of the latter (Figure 5b).
Generation of ‘extra’ sense RNA really did lower the
potency of siRNA since knockdown of p53 was less ex-
tensive (Figure 5c). In a reciprocal experiment, ligating an
antisense-expression cassette to the siRNA cassette
(siRNA-antisense), we found that the potency of the
siRNA was signiﬁcantly enhanced, with the level of anti-
sense RNA being twice that of the sense RNA (Figure 5b
and c). We also mapped the siRNA effectors generated
from various siRNA and shRNA vectors via RT-PCR
to demonstrate their sequence identity. As shown in
Supplementary Figure 4, the sequence of the sense RNA
and antisense RNA generated from each respective cas-
sette were identical. Combination of their expression
proﬁling with the mapping data supported that the
siRNA effectors made from siRNA versus shRNA
vectors were identical. Clearly, unilateral increase in the
level of the sense RNA reduced the potency of the siRNA
while an elevated level of the antisense RNA enhanced
such potency.
In order to evaluate whether the integral sense compo-
nent also regulates the potency of shRNA, we ligated the
shRNA cassette with the sense-expression cassette
(shRNA-sense). As expected, the potency of shRNA fell
markedly upon concomitant expression of the sense RNA
(Figure 5b and d). In a reciprocal experiment, ligating
the shRNA cassette with an antisense-expression cassette
(shRNA-antisense), we found that expression of the anti-
sense strand enhanced the potency of shRNA. All these
observations together indicate that siRNA duplexes ex-
hibit strand antagonism and the sense component nega-
tively interferes with RNAi, presumably behaving as a
substrate for RISC.
We have also developed the Tet-regulated siRNA
system, including four TetO-tethered siRNA-expression
cassettes targeting ﬁreﬂy luciferase (Figure 2a) and the
Dual-Luciferase Reporter, to test strand antagonism.
Renilla luciferase reporter was used as an internal control
to reduce the signiﬁcant reading variations existing in luci-
ferase assay. We found siRNA(O’), in which the sense
RNA was driven by an inducible promoter, displayed
further potency increase following initial dox titration
(5, 10, 25nM), but such enhancement trend reversed fol-
lowing continuous dox titration (Supplementary
Figure 5). It supposed that the inducible level of RNA
was dependent on the dox concentration, i.e. low concen-
tration marginally induced RNA expression while high
concentration restored RNA expression as we proved pre-
viously (22). This was in contrast to siRNA(O) and
siRNA(O2) which displayed potency increase with dox
titration from low concentration to high concentration
(Supplementary Figure 5). These data also supported ex-
istence of sense RNA negative effect in siRNA-mediated
gene knockdown.
Disruption of molar equivalence rendered siRNA
functional in stably transducted cell
Our group and others have demonstrated that
opposing-promoter cassettes are very useful for the gener-
ation of siRNA libraries (6–8). When such a cassette is
functional in stable transduction, it should have broad
application in many contexts. Our discovery of strand an-
tagonism suggested a potential strategy for enhancing
siRNA potency via adjustment of the relative levels of
the antisense and sense components during their gener-
ation. As reported previously, the combination of Pol II
with a pol II promoter (36–38) or of Pol II with a pol III
promoter (39) has a signiﬁcant positive effect on RNA
transcription. Therefore, we ligated a TATA box-deleted
U6 promoter to an intact U6 promoter to generate a pol
III/pol III chimeric promoter (Supplementary Figure 6a)
and examined whether this combination enhanced the
transcription of siRNA. Deletion of the TATA box
from the upstream U6 promoter was designed to prevent
Figure 4. (a) Production of the viral vector in 293FT cells transfected
with pSD31-siRNA, pSD31-siRNA(O), pSD31-siRNA(O’) and pSD31-
siRNA(O2) respectively, namely, the response to unilateral reduction in
the level of antisense RNA (i), in response to that of sense RNA (iii), in
response to reversal these parameter (ii and iv), and in response to
simultaneous reductions in levels of both sense and antisense RNA
(v). The vector stocks were diluted 1000- and 3000-fold for tittering.
(b) The effect of regular expression (+) and an  20% reduction ( )i n
the level of the sense or the antisense RNA or both on production of
the viral vector. The vector titers shown are derived from results of an
experiment that was conducted in triplicate for each sample.
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(Supplementary Figure 6a). We constructed a siRNA-
expression cassette with chimeric promoters, hU6/
U6-siRNA-mU6/U6, with a human U6 chimeric promoter
(hU6/U6) and a mouse U6 chimeric promoter (mU6/U6)
to avoid long sequence repetition that destabilizes DNA
(Figure 6a).
Analysis after transfection of 293T cells with chimeric
hU6/U6-siRNA-mU6/U6 in parallel with regular hU6-
siRNA-mU6 via the vector pSD31 indicated that the
former was more potent than the latter in knockdown of
p53 expression (Supplementary Figure 6b), with  50%
more siRNA transcripts generated in the former case
than in the latter (Supplementary Figure 6c). We then
used the chimeric promoter to construct a variety of
siRNA-expression cassettes, including symmetric hU6/
U6-siRNA-mU6/U6 and hU6/U6-siRNA-O/mU6/U6 and
asymmetric hU6-siRNA-O/mU6/U6 and hU6/O-siRNA-
mU6/U6 (Figure 6a). In the various cassettes, the mouse
U6 promoter (mU6) and the corresponding chimeric
promoter (mU6/U6) drove transcription of the antisense
strand, while the human promoter (hU6) and the corres-
ponding chimeric promoter (hU6/U6) drove transcription
of the sense strand. As shown in Figure 6b and c, stable
transduction with the vector that harbored the symmetric
hU6/U6-siRNA-mU6/U6 and hU6/U6-siRNA-O/mU6/U6
has almost no effect on the expression of p53, as was the
case with hU6-siRNA-mU6, indicating that simultaneous
increases in levels of both strands of siRNA duplexes had
no signiﬁcant effect on RNAi, at least in stable transduc-
tion experiments. By contrast, stable transduction with
asymmetric hU6-siRNA-mU6/U6, hU6/O-siRNA-mU6/
U6 and hU6-siRNA-O/mU6/U6, such that the chimeric
promoter generated more antisense strand than sense
strand (Supplementary Figure 6d), resulted in obvious
knockdown of p53 at the level of both the protein
(>50%; Figure 6b) and its mRNA (>70%; Figure 6c).
To our knowledge, this is the ﬁrst report of siRNA, de-
livered by a lentivector, having substantial ability to
disrupt expression of a target gene, even though its
potency remained much lower than that of shRNA.
Using asymmetric hU6/O-siRNA-mU6/U6 and hU6-
siRNA-O/mU6/U6, we found that the former cassette, des-
pite generation of more antisense RNA and less sense
RNA than the latter, did not further enhance the potency
of the siRNA (Figure 6b and c). This observation hints
Figure 5. (a) Schematic representation of siRNA- and shRNA-expression cassettes ligated with sense- or antisense-expression cassettes, as indicated,
for conﬁrmation of strand antagonism. (b) Relative levels of siRNA duplexes and shRNA in 293FT cells transfected with siRNA-sense,
siRNA-antisense, shRNA-sense and shRNA-antisense vectors in parallel. The data shown are relative to levels of siRNA duplexes in 293FT cells
transfected with pSD31-siRNA. All samples were analyzed in triplicate. (c) Western blotting analyses of the effects of generation of ‘extra’ sense or
antisense RNA on siRNA-mediated knockdown of expression of p53. (d) The effects of generation of ‘extra’ sense and antisense RNA on
shRNA-mediated knockdown of expression of p53, as determined by western blotting.
Nucleic Acids Research,2012, Vol.40, No. 4 1803that the potential reward might not extend indeﬁnitely
with further alterations in the proportions of two
strands. Prior to a given ratio of levels, there is enhance-
ment of RNAi; beyond that point, the opposite occurs.
This conclusion is consistent with the previous observa-
tion that the complete absence of the sense strand does not
enhance RNAi (8). In an ongoing experiment aimed at
further proving less sense RNA is beneﬁcial, we
co-transfected the antisense oligo at ﬁxed concentration
(15nM) with the sense oligo varying at concentration
from 5 to 40nM. We found RNAi with the sense RNA
at lower concentration than 15nM was much potent that
at higher concentration (Figure 7a and b). Combination of
these data also supported the sense RNA and antisense
RNA exerts strand antagonistic effect during RNA inter-
ference and less sense RNA is beneﬁcial.
Mechanistic differences between the siRNA and shRNA in
the induction of RNAi
The events that occur during RNAi, from incorporation
of the siRNA duplex to degradation of the target mRNA,
have been well studied (Figure 1). The key complex of
antisense–RISC, after one round of activity, can be
recycled, with multiple turnovers, to destroy all comple-
mentary RNAs (1,11). In the case of siRNA duplexes
generated within cells, it is very possible that only part
of the nascent sense RNA forms base pairs with the anti-
sense RNA because of the cellular environment wherein
various macromolecules interfere with one another.
Unpaired sense RNAs might be diverted directly to the
antisense–RISC complex and might, thus, compete with
the real target (Figure 1). The strand antagonism observed
in the present study strongly supports the possibility that
sense RNAs do, indeed, reduce the levels of effectors of
RNAi that are available for the real target, reducing the
extent of RNAi. Our observations also help to clarify the
fate of sense RNA in the initiation of RNAi. They appear
to act as the ﬁrst turned-over substrate, after cleavage
within the loaded RISC complex (Figure 1). Then subse-
quent turnover of the true RNA substrates is triggered.
In the case of shRNA, the loop sequence linking the
sense and antisense strand together lowers the kinetic
barrier for duplex formation signiﬁcantly (Figure 1).
More importantly, the hairpin structure renders shRNA
itself and other RNAs harboring shRNA structure poor
targets for RNAi, as demonstrated previously (8,40–43).
This scenario stands in signiﬁcant in contrast to that
involving siRNA since the free sense RNA is an inevitable
substrate of RNAi and, once recruited to the active anti-
sense–RISC complex, it reduces the potency of RNAi.
Thus, the present study provides new insight into RNAi,
and in particular, into the way in which the sense RNA
reduces the potency of siRNA.
The negative effect of the integral sense RNA is intrinsic
and, even after further optimization, must always exist,
preventing siRNA from being as effective as shRNA.
However, by adjusting the molar ratio of antisense to
sense RNA, namely, by over-expressing the antisense
Figure 6. (a) Schematic representation of symmetric and asymmetric siRNA-expression cassettes, with the expression of either the sense or the
antisense RNA or both being driven by a chimeric promoter(s) for disruption of their equivalent molar levels of production. (b) Western blotting
analysis of knockdown of p53 expression in 293FT cells transduced with shRNA and with various siRNA-expression cassettes via lentivector pSD31.
(c) Levels of expression of p53 mRNA in transduced 293FT cells, as determined by real-time RT-PCR. The data shown are relative to levels of p53
mRNA in pSD31-transduced 293FT cells. Data shown are derived from an experiment that was conducted in triplicate for each sample.
1804 Nucleic Acids Research, 2012,Vol.40, No. 4strand of siRNA relative to the sense strand, we were able
to enhance the activity of siRNA in cells to a signiﬁcant
extent. As a result, we were able, for the ﬁrst time, to
suppress expression of a target gene using
siRNA-expression vectors in transduced cells. Our
strategy, the over-expression of the antisense strand,
might also be useful for enhancing the activity of widely
used shRNA-expression vectors.
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